Ganapathi R. Revankar

4.9k citations

163 papers · 3.9k indexed · 1 hit paper · h-index 32

Organic Chemistry top 1%
- Synthesis and Characterization of Heterocyclic Compounds 45
- Carbohydrate Chemistry and Synthesis 26
- Synthesis and Biological Evaluation 24
Physiology top 2%
Infectious Diseases top 2%
- HIV/AIDS drug development and treatment 35
Computational Theory and Mathematics top 1%
Molecular Biology top 5%
- Biochemical and Molecular Research 53
- DNA and Nucleic Acid Chemistry 26
- Advanced biosensing and bioanalysis techniques 17
Epidemiology
- Cytomegalovirus and herpesvirus research 22

Co-authors: Roland K. Robins Arup K. Ghose Vellarkad N. Viswanadhan Howard B. Cottam Zygmunt Kazimierczuk Leroy B. Townsend Patricia A. McKernan T. Sudhakar Rao
Cited by: Organic Chemistry Physiology Infectious Diseases
Journals: Chemical Reviews (1 paper)Proceedings of the National Academy of Sciences (1 paper)Journal of the American Chemical Society (2 papers)
Partner nations: United States India France

In The Last Decade

Ganapathi R. Revankar

156 papers receiving 3.5k citations

Hit Papers

align trajectories log scale

Peers

Countries citing papers authored by Ganapathi R. Revankar

Since Specialization

Citations

This map shows the geographic impact of Ganapathi R. Revankar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ganapathi R. Revankar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ganapathi R. Revankar more than expected).

Fields of papers citing papers by Ganapathi R. Revankar

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ganapathi R. Revankar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ganapathi R. Revankar. The network helps show where Ganapathi R. Revankar may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Ganapathi R. Revankar, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Ganapathi R. Revankar Line = papers co-authored together Ganapathi R. Revankar links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Sequence-Specific Inhibition of the Tumor Necrosis Factor-α Receptor I Gene by Oligodeoxynucleotides Containing N ₇ Modified 2′-Deoxyguanosine Antisense and Nucleic Acid Drug Development ·J O Ojwang,A. F. LEWIS,Ganapathi R. Revankar,David Walker,Taishin Akiyama,Michael E. Hogan,Robert F. Rando	1997	2
2	Effect of β-enantiomeric and racemic nucleoside analogues on mitochondrial functions in HepG2 cells Biochemical Pharmacology ·Lixin Cui,Raymond F. Schinazi,Gilles Gosselin,Jean-Louis Imbach,Chung K. Chu,Robert F. Rando,Ganapathi R. Revankar,Jean‐Pierre Sommadossi	1996	41
3	Azole substituted oligonucleotides promote antiparallel triplex formation at non-homopurine duplex targets Nucleic Acids Research ·Ross H. Durland,T. Sudhakar Rao,Varun Bodepudi,Dale M. Seth,Krishna Jayaraman,Ganapathi R. Revankar	1995	39
4	Triplex formation at the rat neu gene utilizing imidazole and 2'-deoxy-6-thioguanosine base substitutions Biochemistry ·Jay E. Gee,Ganapathi R. Revankar,T. Sudhakar Rao,Michael E. Hogan	1995	27
5	Broad-spectrum activity of 8-chloro-7-deazaguanosine against RNA virus infections in mice and rats Antiviral Research ·Donald F. Smee,H A Alaghamandan,K. Ramasamy,Ganapathi R. Revankar	1995	15
6	Selective Binding of Pyrido[2,3-d]pyrimidine 2'-Deoxyribonucleoside to AT Base Pairs in Antiparallel Triple Helixes Bioconjugate Chemistry ·Ross H. Durland,T. Sudhakar Rao,Krishna Jayaraman,Ganapathi R. Revankar	1995	3
7	Synthesis of Certain Acyclic Nucleoside Analogs of 1,2,4-Triazolo[3,4-f][1,2,4]triazine and Pyrimido[5,4-d]pyrimidine Nucleosides and Nucleotides ·T. Sudhakar Rao,Ganapathi R. Revankar	1995	8
8	Growth inhibition and induction of cellular differentiation of human myeloid leukemia cells in culture by carbamoyl congeners of ribavirin Journal of Medicinal Chemistry ·Yogesh S. Sanghvi,Birendra K. Bhattacharya,Ganesh D. Kini,Steven S. Matsumoto,Steven B. Larson,Weldon B. Jolley,Roland K. Robins,Ganapathi R. Revankar	1990	81
9	Synthesis and antitumor evaluation in mice of certain 7-deazapurine (pyrrolo[2,3-d]pyrimidine) and 3-deazapurine (imidazo[4,5-c]pyridine) nucleosides structurally related to sulfenosine, sulfinosine, and sulfonosine Journal of Medicinal Chemistry ·K. Ramasamy,Nobutaka Imamura,Naeem B. Hanna,Rick A. Finch,Thomas L. Avery,Roland K. Robins,Ganapathi R. Revankar	1990	28
10	Oxidation of 2-amino-9-β-d-ribofurnosylpurine-6-sulfenamide to the corresponding 6-sulfonamide facilitates changes in biologic characterization that include activity against thiopurine-refractory experimental leukemia Cancer Letters ·Rick A. Finch,Karen M. Vásquez,Naeem B. Hanna,Ganapathi R. Revankar,R. K. ROBINS,Thomas L. Avery	1990	2
11	Inhibition of pyrimidine metabolism in myeloid leukemia cells by triazole and pyrazole nucleosides Biochemical Pharmacology ·Steven S. Matsumoto,James M. Fujihaki,L. Dee Nord,Randall C. Willis,Vincent M. Lee,Brahma S. Sharma,Yogesh S. Sanghvi,Ganesh D. Kini,Ganapathi R. Revankar,Roland K. Robins,Weldon B. Jolley,Roberts A. Smith	1990	6
12	Synthesis and in vivo antitumor activity of 2-amino-9H-purine-6-sulfenamide, -sulfinamide, and -sulfonamide and related purine ribonucleosides Journal of Medicinal Chemistry ·Ganapathi R. Revankar,Naeem B. Hanna,Nobutaka Imamura,Arthur F. Lewis,Steven B. Larson,Rick A. Finch,Thomas L. Avery,Roland K. Robins	1990	32
13	USE OF THE SODIUM SALT GLYCOSYLATION HETBOD IN NUCLEOSIDE SYNTHESIS Nucleosides and Nucleotides ·Ganapathi R. Revankar,Roland K. Robins	1989	10
14	Inhibition of phosphoribosylpyrophosphate synthetase by 4-methoxy-(MRPP) and 4-amino-8-(d-ribofuranosylamino)pyrimido[5,4-d]pyrimidine (ARPP) Biochemical Pharmacology ·L. Dee Nord,Randall C. Willis,Timothy S. Breen,Thomas L. Avery,Rick A. Finch,Yogesh S. Sanghvi,Ganapathi R. Revankar,Roland K. Robins	1989	7
15	Antitumor and antiviral activity of synthetic .alpha.- and .beta.-ribonucleosides of certain substituted pyrimido[5,4-d]pyrimidines: a new synthetic strategy for exocyclic aminonucleosides Journal of Medicinal Chemistry ·Yogesh S. Sanghvi,Steven B. Larson,Steven S. Matsumoto,L. Dee Nord,Donald F. Smee,Randall C. Willis,Thomas L. Avery,Roland K. Robins,Ganapathi R. Revankar	1989	58
16	Synthesis and biological evaluation of certain 3-.beta.-D-ribofuranosyl-1,2,4-triazolo[4,3-b]pyridazines related to formycin prepared via ring closure of pyridazine precursors Journal of Medicinal Chemistry ·Yonghan Kang,Steven Larson,Roland K. Robins,Ganapathi R. Revankar	1989	5
17	Nucleoside and nucleotide modulation of genetic expression — A new approach to chemotherapy Advances in Enzyme Regulation ·Roland K. Robins,Emmanuel A. Ojo-Amaize,Zahra Parandoosh,Howard B. Cottam,Steven S. Matsumoto,Ganapathi R. Revankar,Donald F. Smee,James M. Fujitaki,Randall C. Willis,Boanerges Rubalcava,L. Dee Nord,Weldon B. Jolley	1989	9
18	Antiviral activities of 2′-deoxyribofuranosyl and arabinofuranosyl analogs of sangivamycin against retro- and DNA viruses Antiviral Research ·Donald F. Smee,Patricia A. McKernan,H A Alaghamandan,Karl Frank,K. Ramasamy,Ganapathi R. Revankar,Roland K. Robins	1988	8
19	Inhibition of orotidylate decarboxylase by 4(5H)-oxo-1-β-d-ribofuranosylpyrazolo[3,4-d] pyrimidine-3-thiocarboxamide (APR-TC) in B lymphoblasts Biochemical Pharmacology ·L. Dee Nord,Randall C. Willis,Donald F. Smee,Timothy A. Riley,Ganapathi R. Revankar,Roland K. Robins	1988	9
20	Synthesis of 5′-O-β-d-glucopyranosyl and 5′-O-β-d-galactopyranosyl derivatives of ribavirin Carbohydrate Research ·Naeem B. Hanna,Roland K. Robins,Ganapathi R. Revankar	1987	3

About Ganapathi R. Revankar

Ganapathi R. Revankar is a scholar working on Organic Chemistry, Infectious Diseases and Molecular Biology, having authored 163 papers that have together received 3.9k indexed citations. Recurring topics across this work include Biochemical and Molecular Research (53 papers), Synthesis and Characterization of Heterocyclic Compounds (45 papers), HIV/AIDS drug development and treatment (35 papers), DNA and Nucleic Acid Chemistry (26 papers), Carbohydrate Chemistry and Synthesis (26 papers), Synthesis and Biological Evaluation (24 papers), Cytomegalovirus and herpesvirus research (22 papers) and Advanced biosensing and bioanalysis techniques (17 papers). The work is most often cited by research in Organic Chemistry (1.9k citations), Physiology (168 citations) and Infectious Diseases (602 citations). Ganapathi R. Revankar has collaborated with scholars based in United States, India and France. Frequent co-authors include Roland K. Robins, Arup K. Ghose, Vellarkad N. Viswanadhan, Howard B. Cottam, Zygmunt Kazimierczuk, Leroy B. Townsend, Patricia A. McKernan, T. Sudhakar Rao, K. Ramasamy and Steven B. Larson. Their work appears in journals such as Chemical Reviews, Proceedings of the National Academy of Sciences and Journal of the American Chemical Society.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact